Table 1.
Number | % | |
---|---|---|
Age | ||
Median, 57 years; Range, 47 – 73 years | ||
Pathology | ||
Serous | 10 | 48% |
Clear cell | 4 | 19% |
Peritoneal | 1 | 5% |
Endometrioid | 2 | 9% |
Transitional | 1 | 5% |
Mixed | 3 | 14% |
Initial Stage | ||
I | 1 | 5% |
II | 3 | 14% |
III | 12 | 57% |
IV | 5 | 24% |
Prior Treatment | ||
2 regimens | 1 | 5% |
3 regimens | 5 | 24% |
4 regimens | 6 | 28% |
5 regimens | 4 | 19% |
6 regimens or more | 5 | 24% |
Platinum and Taxane Sensitivity | ||
Resistant | 10 | 48% |
Refractory | 11 | 52% |